JENNIFER GALEY: Open Payments
NPI 1285062521 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$922 in 50 payments from 16 companies in 2025. Trend: 2023 $1,020 · 2024 $1,220 · 2025 $922
Food & beverage: $922
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $247 |
| Axsome Therapeutics, Inc. | 8 | $138 |
| PFIZER INC. | 5 | $97 |
| Astellas Pharma US Inc | 4 | $94 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $52 |
| AstraZeneca Pharmaceuticals LP | 2 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Seqirus USA Inc | 2 | $36 |
| Lilly USA, LLC | 2 | $35 |
| Daiichi Sankyo Inc. | 1 | $28 |
Products named: Auvelity, VRAYLAR, PREVNAR 20, Veozah, QULIPTA, UBRELVY, CAPLYTA, MOUNJARO.
Industry payments across TX — which companies pay providers there.
